These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 4715887

  • 1. [Principles of chronic hormone substitution].
    Mosonyi L.
    Z Gesamte Inn Med; 1973 Apr 01; 28(7):105-11. PubMed ID: 4715887
    [No Abstract] [Full Text] [Related]

  • 2. [Results of pregnancy in women with endocrinopathy or receiving long-term hormone treatment (author's transl)].
    Hníková O, Cízková-Písarovicová J.
    Cas Lek Cesk; 1977 Sep 09; 116(36):1108-11. PubMed ID: 912725
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment of growth disorders].
    Suárez M.
    Minerva Pediatr; 1966 Oct 13; 18(30):1818-33. PubMed ID: 5995747
    [No Abstract] [Full Text] [Related]

  • 6. The use of hormones in the treatment of obesity.
    Rivlin RS.
    Curr Concepts Nutr; 1975 Oct 13; 3():151-62. PubMed ID: 1093810
    [No Abstract] [Full Text] [Related]

  • 7. [Hormone therapy of eye diseases (review of the literature)].
    Margolis MG.
    Vestn Oftalmol; 1967 Oct 13; 80(1):79-84. PubMed ID: 4311943
    [No Abstract] [Full Text] [Related]

  • 8. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1980 May 30; 22(11):45-6. PubMed ID: 7374621
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Therapeutic problems in hormone-dependent cancer].
    Zimel H.
    Stud Cercet Endocrinol; 1969 May 30; 20(2):111-25. PubMed ID: 4898947
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Nephrotropic hormone effects].
    Kaiser W, Mampel E, Fehér L, Oravec D.
    Z Gesamte Inn Med; 1972 Apr 15; 27(8):348-54. PubMed ID: 5054182
    [No Abstract] [Full Text] [Related]

  • 16. [Male osteoporosis: current treatments and future options].
    Romagnoli E, Paglia F, Dionisi S, De Geronimo S, Pepe J, Di Virgilio R, Minisola S.
    Clin Ter; 2003 Apr 15; 154(1):49-53. PubMed ID: 12854284
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Changes in the blood picture in therapeutic use of hormones].
    Bucher U.
    Dtsch Med Wochenschr; 1970 Apr 17; 95(16):901-2. PubMed ID: 5439546
    [Abstract] [Full Text] [Related]

  • 19. [New therapy for severe osteoporosis. Bone development with parathyroid hormone? (interview by Brigitte Moreano)].
    Ringe JD.
    MMW Fortschr Med; 2001 May 31; 143(22):10. PubMed ID: 11460391
    [No Abstract] [Full Text] [Related]

  • 20. Past and future of anabolic agents.
    Ringe JD.
    Ann Med Interne (Paris); 2000 Oct 31; 151(6):482-9. PubMed ID: 11104928
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.